v3.23.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Research and development (“R&D”) expenses, net $ 5,641 $ 3,536 $ 14,023 $ 13,049
Amortization of intangible assets 380 1,139
General and administrative expenses 2,154 2,633 6,053 7,471
Operating loss 7,795 6,549 20,076 21,659
Other income (89) (52) (270) (52)
Interest expenses 574 555 1,884 1,504
Finance income, net (382) (280) (1,034) (706)
Loss before tax 7,898 6,772 20,656 22,405
Tax expenses 8 8 22 26
Net loss $ 7,906 $ 6,780 $ 20,678 $ 22,431
Basic loss per share of Common Stock (in Dollars per share) $ 0.13 $ 0.23 $ 0.43 $ 0.75
Weighted average number of shares of Common Stock outstanding, basic (in Shares) 60,587,718 29,907,812 48,196,566 29,812,542

Source